Clinical Trial Update: Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine with Abraxane and other investigational therapies as neoadjuvant treatment for pancreatic adenocarcinoma has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Florida | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-02-09